EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers

Jie Wang iD, Qi Huang, Xing Chen, Zhiwen You, Kun He, Xiaoxie Mao, Yiyun Huang, Nicolai Franzmeier, Michael Schöll, Tengfei Guo, Jun Zhao, Yihui Guan und 3 weitere

Alzheimer's & Dementia · 2025

DOI: 10.1002/alz.70333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Jie Wang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: tau Proteins, Alzheimer Disease, Synapses, Cognitive Dysfunction. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: STI2030-Major Projects, National Science Foundation of China, Shanghai Sailing Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION We investigated the associations of longitudinal synaptic loss and cognitive decline with tau burden and plasma biomarkers in Alzheimer's disease (AD). METHODS Twenty cognitively impaired (CI) individuals and 16 healthy controls (HC) underwent cognitive and plasma biomarker assessments, amyloid positron emission tomography (PET), tau PET, and synaptic density PET; after 1 year, tau and synaptic density PET were repeated. The relationships among tau burden, plasma biomarkers, synaptic density, and cognition were investigated. RESULTS The CI group had more longitudinal synapse loss and tau deposition than HCs. Longitudinal synaptic loss was positively associated with longitudinal cognitive decline, negatively with longitudinal tau deposition. Plasma glial fibrillary acidic protein (GFAP) mediates the relationship between longitudinal tau deposition and longitudinal synaptic loss. Tau burden, plasma phosphorylated tau181, and GFAP could predict longitudinal synaptic loss and cognitive decline. CONCLUSIONS The CI group had more longitudinal synapse loss and tau burden increases than HCs. Tau pathology and plasma GFAP could predict longitudinal synapse loss and cognitive decline. Highlights Cognitively impaired individuals had more longitudinal synapse loss in the medial temporal lobe, and increased tau burden in the widespread neocortex than healthy controls. The longitudinal change of synaptic density was negatively associated with the longitudinal change of tau burden, and positively associated with longitudinal cognitive decline. Plasma glial fibrillary acidic protein (GFAP) mediates the relationship between longitudinal tau deposition and longitudinal synaptic loss. Tau burden, plasma phosphorylated tau181, and GFAP could predict longitudinal synaptic loss and cognitive decline.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

tau ProteinsAlzheimer DiseaseSynapsesCognitive DysfunctionHumansPositron-Emission TomographyMaleFemaleBiomarkersAgedGlial Fibrillary Acidic ProteinLongitudinal StudiesBrainMiddle Aged

Stichwörter der Autor:innen

cognitionlongitudinal synapse lossplasma glial fibrillary acidic proteinplasma phosphorylated tau 181synaptic densitytau burden

Substanzen

tau ProteinsBiomarkersGlial Fibrillary Acidic ProteinMAPT protein, human

Autor:innen und Institutionen

  • Department of Nuclear Medicine & PET Center, Huashan Hospital, Fudan University, Shanghai, China.
  • Department of Nuclear Medicine, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • PET Center, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, Connecticut, USA.
  • Institute for Stroke and Dementia Research (ISD), LMU University Hospital, Ludwig-Maximilians-University (LMU), Munich, Germany.
  • Institute of Neuroscience and Physiology, Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Department of Psychiatry and Neurochemistry, University of Gothenburg, The Sahlgrenska Academy, Institute of Neuroscience and Physiology, Gothenburg, Sweden.

ORCID-Profile: Jie Wang, Fang Xie

Förderung

  • STI2030-Major Projects
  • National Science Foundation of China
  • Shanghai Sailing Program
  • startup fund of Huashan Hospital, Fudan University
  • Shanghai Municipal Key Clinical Specialty
  • Shanghai Municipal Science and Technology Major Project
  • ZJLab Clinical Research Plan of SHDC
  • National Natural Science Foundation of China

Zitieren

APA

Wang, J., Huang, Q., Chen, X., You, Z., He, K., Mao, X., Huang, Y., Franzmeier, N., Schöll, M., Guo, T., Zhao, J., Guan, Y., Ni, R., Li, B., & Xie, F. (2025). Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70333

Vancouver

Wang J, Huang Q, Chen X, You Z, He K, Mao X, et al. Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70333

BibTeX
@article{Wang2025,
  author = {Wang, Jie and Huang, Qi and Chen, Xing and You, Zhiwen and He, Kun and Mao, Xiaoxie and Huang, Yiyun and Franzmeier, Nicolai and Schöll, Michael and Guo, Tengfei and Zhao, Jun and Guan, Yihui and Ni, Ruiqing and Li, Binyin and Xie, Fang},
  title = {Prediction of longitudinal synaptic loss in Alzheimer's disease using tau PET and plasma biomarkers},
  journal = {Alzheimer's & Dementia},
  year = {2025},
  doi = {10.1002/alz.70333}
}
Kostenlos starten →